Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.
about
Specific deficiency in nuclear factor-kappaB activation in neurons of the central nervous systemPathological survivin expression links viral infections with pathogenesis of erosive rheumatoid arthritisThe transcription factor IRF8 activates integrin-mediated TGF-β signaling and promotes neuroinflammation.A novel role for interferon regulatory factor 1 (IRF1) in regulation of bone metabolismThe immune tolerance network and rheumatic disease: immune tolerance comes to the clinic.Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitisGenomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosusAn approach to identify over-represented cis-elements in related sequences.Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts.NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets.Interferons as pathogenic effectors in autoimmunity.Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop.Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.Interleukin 6 is required for the development of collagen-induced arthritisSuppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signalingOverexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitisK63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5.Regulation of T helper cell differentiation by interferon regulatory factor family members.Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity.K63-linked polyubiquitination of IRF1: an essential step in the IL-1 signaling cascade.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis.Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease.Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.Type I interferons.Enhanced expression of interferon regulatory factor-1 in the mucosa of children with celiac disease.Protection from autoimmune brain inflammation in mice lacking IFN-regulatory factor-1 is associated with Th2-type cytokines.Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice.Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice.Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
P2860
Q28216156-4238FC26-6AB8-43F8-AFD7-2B021A561055Q28236801-D3FD9D4B-55D1-4E74-A037-81BEB2D5A5BDQ33927253-FAE52155-6929-4B67-AB17-396DF27AAB8BQ34122992-571F5043-7BA1-4056-B408-AFC2289871CDQ34338802-1E13B83F-2C0A-43C9-88AC-A0F4E7A98E1DQ34544891-87E5B17A-C320-439B-B865-765B524039D4Q34672353-9FF86CBD-098C-4AEF-BBFC-AC3713F37867Q34905750-33C3DC35-8446-4F33-9B8F-A6FAB84C847AQ35554043-5E99950D-69D1-4547-84D4-0D0ECD5501F4Q35675526-4F1313B0-3B35-44D3-AC9A-6612DC7E0860Q35912886-3B9CF377-16DF-4438-80BC-C4681A535949Q36056835-5A97FB7C-6977-4F3D-9195-5DA7347E88F2Q36079852-601160FD-A0AD-42F4-B11B-0ADEB73F8495Q36299846-8F0CB85C-F644-4592-9374-7DC6274CB31CQ36370602-C830A3E8-AA01-40AD-AA9C-0901C10A8C5FQ36400353-942A5FAA-D240-486D-89EE-7DAF24826B08Q36588130-D8E31773-9380-4EFE-8491-7D0B6C257025Q37165163-9DCE4639-574F-426F-A15E-76763BF33353Q37686404-926EAA93-906C-4601-9E1E-1BEA924AD97BQ38004975-F37ECF7E-3651-402F-95B6-E6DD5CDB64F1Q38161582-1568096E-52CE-41CF-B60A-CC87DFC4F97DQ38209104-C42E9559-7DDD-4815-BB7A-CE2734A0677CQ38335622-550772CE-D4AD-4168-928D-4BFC6B09CF51Q40085017-640A9B0F-A9D7-4E3D-986B-EBA08455C9D3Q40254093-A91E2DDF-62AA-4220-8562-793AB6D591A6Q43865165-7FA86065-1BBB-49D8-9E23-4C0CF886CC8CQ44572874-558818B6-0CBB-4148-BB8D-FA8FC5AB501AQ47858008-DF652BD5-2773-4E56-B81D-61ED233718AAQ48280785-EFFC7A6A-D035-4E26-A0A4-C74E16027681Q50776402-5777642E-F6F8-4732-9EEB-0A9FBC712911Q51757901-CA6F6161-0192-4053-9FDD-F3FC7C422910Q54192217-5EAA5369-1953-4111-A3C9-85C57F6C82AF
P2860
Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Reduced incidence and severity ...... nterferon regulatory factor-1.
@en
type
label
Reduced incidence and severity ...... nterferon regulatory factor-1.
@en
prefLabel
Reduced incidence and severity ...... nterferon regulatory factor-1.
@en
P2093
P2860
P356
P1476
Reduced incidence and severity ...... nterferon regulatory factor-1.
@en
P2093
P2860
P304
P356
10.1084/JEM.185.2.231
P407
P577
1997-01-01T00:00:00Z